In glioma cells treated with a low concentration of arsenic trioxide (2 μM), the cell cycle was blocked in G2/M phase [20], and the levels of cyclinB1, aurora kinase A, and phosphorylated aurora kinase A decreased in a dose-dependent manner. Here, AURKA is linked to central nervous system cancer.